Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

NCT00006903 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

67

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Uterine Corpus Carcinoma
Stage III Uterine Corpus Cancer AJCC v7
Stage IV Uterine Corpus Cancer AJCC v7

Interventions

DRUG: Fulvestrant

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]